NCT01560416 Fulvestrant With or Without Ganetespib in HR+ Breast Cancer Status COMPLETED Phase PHASE2
NCT01551693 STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma Status TERMINATED Phase PHASE2
NCT01550458 Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01543620 Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT01534078 Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01523977 Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Status COMPLETED Phase PHASE1
NCT01522768 Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer Status COMPLETED Phase PHASE2
NCT01516216 Study of Vitamin D in Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01494662 HKI-272 for HER2-Positive Breast Cancer and Brain Metastases Status COMPLETED Phase PHASE2
NCT01485744 LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01484314 Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma Status TERMINATED Phase PHASE2
NCT01472627 Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro Status COMPLETED Phase N/A
NCT01470196 Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT01468649 Real-Time Near-infrared (NIR) Mapping of Sentinel Lymph Nodes in Breast Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01466036 Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Status COMPLETED Phase PHASE2